Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Biosimilar filgrastim (Zarzio®) vs. lenograstim (Myelostim®) for peripheral blood stem cell mobilization in adult patients with lymphoma and myeloma: a single center experience.
Marchesi F, Vacca M, Gumenyuk S, Pandolfi A, Renzi D, Palombi F, Pisani F, Romano A, Spadea A, Ipsevich F, Santinelli S, De Rienzo M, Papa E, Canfora M, Laurenzi L, Foddai ML, Pierelli L, Mengarelli A. Marchesi F, et al. Among authors: de rienzo m. Leuk Lymphoma. 2016 Feb;57(2):489-492. doi: 10.3109/10428194.2015.1063147. Epub 2015 Jul 18. Leuk Lymphoma. 2016. PMID: 26099572 No abstract available.
Long-Term Persistence and Relevant Therapeutic Impact of High-Titer Viral-Neutralizing Antibody in a Convalescent COVID-19 Plasma Super-Donor: A Case Report.
De Rienzo M, Foddai ML, Conti L, Mandoj C, Iaboni S, Saladini I, Castilletti C, Matusali G, Donno DR, Marchioni L, Ianniello S, Corpolongo A, Palange M, Ciliberto G, Piaggio G, De Marco F. De Rienzo M, et al. Front Immunol. 2021 Aug 23;12:690322. doi: 10.3389/fimmu.2021.690322. eCollection 2021. Front Immunol. 2021. PMID: 34497602 Free PMC article.
Efficacy and safety of biosimilar Peg-filgrastim after autologous stem cell transplant in myeloma and lymphoma patients: a comparative study with biosimilar Filgrastim, Lenograstim, and originator Peg-filgrastim.
Marchesi F, Terrenato I, Papa E, Tomassi M, Falcucci P, Gumenyuk S, Palombi F, Pisani F, Renzi D, Romano A, Spadea A, Regazzo G, Rizzo MG, De Rienzo M, Ripellino C, Sgromo S, Viggiani C, Ponte E, Kayal R, Cordone I, Foddai ML, Mengarelli A. Marchesi F, et al. Among authors: de rienzo m. Ann Hematol. 2024 Mar;103(3):947-956. doi: 10.1007/s00277-023-05604-9. Epub 2024 Jan 8. Ann Hematol. 2024. PMID: 38189833 Free PMC article.
Macroamylasemia in a patient with multiple myeloma.
Sagristani M, Guariglia R, Pocali B, De Rienzo M, Guastafierro S, Romano G, Tirelli A. Sagristani M, et al. Among authors: de rienzo m. Leuk Lymphoma. 2002 Aug;43(8):1705-7. doi: 10.1080/1042819021000003081. Leuk Lymphoma. 2002. PMID: 12400618
Microbial biofilms: biosurfactants as antibiofilm agents.
Banat IM, De Rienzo MA, Quinn GA. Banat IM, et al. Among authors: de rienzo ma. Appl Microbiol Biotechnol. 2014 Dec;98(24):9915-29. doi: 10.1007/s00253-014-6169-6. Epub 2014 Oct 31. Appl Microbiol Biotechnol. 2014. PMID: 25359476 Review.
12 results